View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

SOT: 54th Annual Meeting and ToxExpo, March 22–26, 2015 San Diego, US

NSF International will be attending the 54th Annual Meeting and ToxExpo from 22-26 March at San Diego Convention Center.

The company will be at booth 1108.

NSF Health Sciences supports analytical challenges of the pharmaceutical, biotechnology and medical device industries.

The company’s testing and expertise include extractables / leachables, oligonucleotide and aptamer analysis; clinical / non-clinical bioanalysis, as well as method development and validation.

In addition, NSF has experience in stability testing, and the company’s Applied Research Center advances public health in water, food, pharmaceuticals, and sustainability through R&D, testing, and consulting in chemistry, microbiology, toxicology; and human health risk assessment.

NSF will be doing special presentations through the event, including chemical risk assessment best practices, and molecular thresholds of early key events in phthalate-induced liver tumour outcomes.

Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology